The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation.
about
From BILAG to BILAG-based combined lupus assessment-30 years onCD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysisAPRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritisDrugs in early clinical development for Systemic Lupus Erythematosus.Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide.B-cell-depleting therapy in systemic lupus erythematosus.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.B-cell depletion in the treatment of lupus nephritis.B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.Rituximab biosimilars.Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis.Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.Rituximab and lupus--a promising pair?The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosus.Infectious complications of rituximab therapy in renal disease.Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.Biological therapy in systemic lupus erythematosus.Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).
P2860
Q28081809-FC447687-6FE7-4267-86AE-2D53978545DCQ30388433-B18D9D59-6E17-4F70-AB98-50BCDB14C732Q36219954-9599209E-E7BC-4E3F-8285-A4CA9E4A4BACQ36907709-6DAE147D-4CE3-46F0-A7A0-E392E26D12FFQ37324772-03AA7ACD-F836-4B8B-B68B-FE103A14947EQ37497048-2F9E3A17-0093-40DB-8A62-B40863176014Q37586344-757A3F93-76FE-4DAF-B36E-E755D74A5929Q37922765-CFC81971-DF1A-4A3E-8A89-7A2A79D44AADQ38026784-882D11CF-9EE3-4122-A20E-0D44F04CD417Q38097129-73D36D3F-DDBD-4604-9B53-7EA132095246Q38100232-00D78D90-9A9F-4925-8BF7-29E48462EF9EQ38153509-14A4E6F1-D092-4FA4-A10C-17FB6DE63FC0Q38175493-771A5735-0028-485B-8AA6-2E453F20E067Q38235185-13B64CB6-4331-4459-9FC3-766ECBACBAADQ38309470-F0D7018E-D131-4473-A8CF-3F99C8E706C3Q40065728-CA50189F-5368-455F-B206-1D70E022CBA8Q40298025-FBD8E12C-AC1F-4E6D-B580-145B1B2CF6FFQ40610167-949CD869-E58F-4632-A2A2-A7426D13A23FQ42141973-467D4384-25E0-4F0E-830F-2E9B98D6E260Q43948799-E3397774-33C7-4142-A60D-A91ADCED3AF2Q51201612-8BA62445-B02A-49E6-AD65-94F86F728D69
P2860
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The efficacy of repeated treat ...... erythematosus: an evaluation.
@en
The efficacy of repeated treat ...... erythematosus: an evaluation.
@nl
type
label
The efficacy of repeated treat ...... erythematosus: an evaluation.
@en
The efficacy of repeated treat ...... erythematosus: an evaluation.
@nl
prefLabel
The efficacy of repeated treat ...... erythematosus: an evaluation.
@en
The efficacy of repeated treat ...... erythematosus: an evaluation.
@nl
P2093
P356
P1433
P1476
The efficacy of repeated treat ...... erythematosus: an evaluation.
@en
P2093
Anisur Rahman
Tabitha Turner-Stokes
P304
P356
10.1093/RHEUMATOLOGY/KER018
P577
2011-03-12T00:00:00Z